Remove 2021 Remove Clinical Pharmacology Remove Documentation
article thumbnail

COVID-19 has propelled the regulatory industry years ahead

pharmaphorum

2 And, as of September 2021, there are 22 COVID-19 vaccines in use globally 3 , and over 2.3 And advances in digitalisation could facilitate a move from document-based submissions to data-based submissions, through a cloud platform like the one being developed by Accumulus Synergy. Last accessed: October 2021. Perspect Clin Res.

Vaccines 143
article thumbnail

The future of medical cannabis development in Europe

European Pharmaceutical Review

5 When these medicines are prescribed to patients, we can use feedback from the real-world data that documents clinical outcomes, efficacy measures, patient-reported outcomes, and adverse events. An observational study of safety and clinical outcome measures across patient groups in the United Kingdom Medical Cannabis Registry.

article thumbnail

NHC Comments on Landmark FDA Guidance for Diversity in Clinical Trials

Putting Patients First Blog

Food and Drug Administration 5630 Fishers Lane Rockville, MD 20852 RE: Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies [Docket No. Clinical Pharmacology & Therapeutics , 97(3) , 263–273. NHC commitment to ensure representativeness in all policy work.